Serological markers of tissue remodeling are elevated in patients with COVID-19 who develop interstitial lung disease
H. Breisnes (Herlev, Denmark), P. Juhl (Herlev, Denmark), D. Leeming (Herlev, Denmark), T. Wilkinson (Southampton, United Kingdom), A. Fazleen (Southampton, United Kingdom), J. Sand (Herlev, Denmark)
Source: International Congress 2022 – Respiratory inflammation and the pulmonary consequences of COVID-19
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Breisnes (Herlev, Denmark), P. Juhl (Herlev, Denmark), D. Leeming (Herlev, Denmark), T. Wilkinson (Southampton, United Kingdom), A. Fazleen (Southampton, United Kingdom), J. Sand (Herlev, Denmark). Serological markers of tissue remodeling are elevated in patients with COVID-19 who develop interstitial lung disease. 4278
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|